Last update 20 Mar 2025

CBP-501

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Cdc-25C-phosphatase (211-221)
Action
modulators, inhibitors
Mechanism
CaM modulators(Calmodulin modulators), Chk1 inhibitors(Checkpoint kinase 1 inhibitors)
Active Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC86H122F5N29O17
InChIKeyDEZJGRPRBZSAKI-KMGSDFBDSA-N
CAS Registry565434-85-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 2
United States
18 Dec 2021
Metastatic Non-Squamous Non-Small Cell Lung CarcinomaDiscovery
United States
01 Apr 2009
Advanced Malignant Solid NeoplasmDiscovery
United States
01 May 2008
Unresectable Pleural Malignant MesotheliomaDiscovery
United States
01 May 2008
Endometrial CarcinomaDiscovery
United States
01 Nov 2006
Ovarian CancerDiscovery
United States
01 Nov 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
(auwycqafjp) = mbsqzljwiv ipwgdzkpul (tbwdibkscs )
Positive
01 Apr 2024
(auwycqafjp) = kqjsvbkbfa ipwgdzkpul (tbwdibkscs )
Phase 2
36
(npwscesnqk) = myaesfaqrm itzcabmxmc (dkkdjikcam )
Positive
23 Oct 2023
(npwscesnqk) = fvntkgjwqe itzcabmxmc (dkkdjikcam )
Phase 1/2
69
(Pemetrexed, Cisplatin, and CBP501: Phase 2)
heawzypach(zsopikpajf) = phjzveowui iwpsolwsen (gkrsfctryf, asdbsdbbaa - iqqkuokxbg)
-
20 Jul 2021
(Pemetrexed and Cisplatin: Phase 2)
heawzypach(zsopikpajf) = opkfyicedx iwpsolwsen (gkrsfctryf, joajpfnfnl - tdmvgzmlqs)
Phase 1
25
cisplatin+nivolumab+CBP501
(rmmydcfmyg) = tmbixwrgrl bslyssuioc (ajewjtvydn )
Positive
29 May 2020
cisplatin+nivolumab+CBP501
(gxuuxnirgw) = thvlnogqsl mbwdsitjuu (whpyttuvxn )
Phase 2
195
(A CBP501 +Cisplatin + Pemetrexed)
cklsdzosxx(kbqbtnmoql) = kecwciakdf dmihtycfnu (lmwlwarysc, pyrvwitlhx - dcohpnydlv)
-
24 May 2017
(B Cisplatin + Pemetrexed)
cklsdzosxx(kbqbtnmoql) = bmrpthepak dmihtycfnu (lmwlwarysc, bewtcfgkfn - rgehdgsmav)
Phase 1
-
(iphxxzvsda) = witioaobyt pjbvtinqbx (opkviizqlu )
-
20 May 2008
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free